RSS Feeds
Exercise and Peripheral Arterial Disease
- Mary M. McDermott, MD;
- Kiang Liu, PhD; and
- Lu Tian, ScD
- From Northwestern University Feinberg School of Medicine, Chicago, IL 60611.
IN RESPONSE:
We agree with Dr. Kim that cilostazol and pentoxifylline, the only 2 U.S. Food and Drug Administration–approved drugs for treating walking impairment in patients with PAD, have modest effects on walking performance in this patient population. Therefore, we repeated the analyses that we reported in our manuscript with additional statistical adjustment for use of pentoxifylline or cilostazol. Our results (Table) did not change …
